Towards the development of standardized potency assays in regenerative medicine bioprocessing for the treatment of ischemic cardiac injury
The mechanisms by which mesenchymal cells can repair the infarcted myocardium are still unclear and are made more challenging by the fact that hMSCs engraft in the myocardium for only a short amount of time. This thesis first examined the ability of commercial bone marrow (BM) MSCs expanded in low s...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747611 |